Back to Journals » Therapeutics and Clinical Risk Management » Volume 10

Review

Emerging treatments in type 2 diabetes: focus on canagliflozin

       
Total article views   HTML views PDF downloads Totals
11,757 Dovepress* 9,595+ 2,466 12,061
PubMed Central* 2,162 972 3,134
Totals 11,757 3,438 15,195
*Since 21 August 2014
+Since July 2016

View citations on PubMed Central and Google Scholar